FdaApplication
NDA 020397
Identifiers
- fda_app_no: NDA020397
Properties
| Property | Value |
|---|---|
| applicant_name | LEGACY PHARMA INC SEZC |
| application_type | NDA |
| approval_date | 1996-11-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET;ORAL |
| ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products